Tag
- Gilead Sciences Reports Q3 2023 Financial Results 2023-11-09
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- FDA Lifts Clinical Hold on Gilead's HIV Drug Lenacapavir 2022-05-18
- Gilead's CD47 Monoclonal Antibody Clinical Trial Was 'Unbloc... 2022-04-20
- Gilead: Remdesivir sold $1.93 billion in Q4 2021-02-08
- Sinopharm and Gilead announce cooperation 2020-09-14
- Pfizer signs deal to manufacture Gilead's remdesivir 2020-08-10
- Gilead announces results from Phase 3 Trial of remdesivir in... 2020-06-15
- Gilead may struggle to expand remdesivir's market to moderat... 2020-05-18
- Gilead's Japanese remdesivir nod, licensing talks; Lilly-Jun... 2020-05-09
Market Analysis
- China’s EVA Market Has Entered a Downward Trend Since May May-15,2026
- Trend Slowing Down! Melamine Enters a Volatile Bottoming-Out Cycle May-15,2026
- Polyester Bottle Flakes Slightly Lowered on May 13, Showing Weak and Volatile Trends May-14,2026
- Weather Themes Remain; Palm Oil Futures Expected to Rise May-14,2026
- This week, the price of anhydrous hydrogen fluoride remained high and stable in China (5.11-5.13) May-14,2026